BiotechTube

Nafamostat Mesilate + Placebo

Phase 1Completed
0 watching 0 views this week💤 Quiet
25
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Pharmacokinetics

Conditions

Pharmacokinetics

Trial Timeline

Sep 21, 2020 → May 14, 2021

NCT ID
NCT04406415

About Nafamostat Mesilate + Placebo

Nafamostat Mesilate + Placebo is a phase 1 stage product being developed by Ensysce Biosciences for Pharmacokinetics. The current trial status is completed. This product is registered under clinical trial identifier NCT04406415. Target conditions include Pharmacokinetics.

Hype Score Breakdown

Clinical
10
Activity
5
Company
2
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT04406415Phase 1Completed

Competing Products

20 competing products in Pharmacokinetics

See all competitors
ProductCompanyStageHype Score
GP30341 capsules 200 mg + Standard therapyGEROPHARMPre-clinical
15
GP40221 + ozempicGEROPHARMPhase 1
25
Memantinol tablets, 20 mg + Akatinol Memantine® tablets, 20 mgGEROPHARMPhase 1
25
Rinsulin NPH + Humulin NPHGEROPHARMPre-clinical
15
Crestor 10mg(Rosuvastatin 10mg), Glucodown OR SR 750mg(Metformin SR 750mg)YuhanPhase 1
33
DS-8500a + ItraconazoleDaiichi SankyoPhase 1
33
Milademetan + Itraconazole + PosaconazoleDaiichi SankyoPhase 1
33
Pexidartinib + ProbenecidDaiichi SankyoPhase 1
33
DS-8500a + RosuvastatinDaiichi SankyoPhase 1
33
DS-8500aDaiichi SankyoPhase 1
33
Milademetan Treatment A + Milademetan Treatment B + Milademetan Treatment CDaiichi SankyoPhase 1
33
tolterodine + mirabegronAstellas PharmaApproved
85
ASP3652Astellas PharmaPhase 1
33
ASP015K ER + ASP015K IRAstellas PharmaPhase 1
33
YM178 modified release (OCAS) + YM178 immediate release (IR)Astellas PharmaPhase 1
33
Isavuconazole + dextromethorphanAstellas PharmaPhase 1
33
mirabegron + metoprololAstellas PharmaPhase 1
33
ASP015KAstellas PharmaPhase 1
33
zolbetuximab + oxaliplatin + leucovorin + fluorouracil + Pembrolizumab + folinic acid + nivolumab + DocetaxelAstellas PharmaPhase 2
52
Isavuconazole + Repaglinide + CaffeineAstellas PharmaPhase 1
33

Other Products from Ensysce Biosciences

PF614 capsule + PlaceboPhase 3
69
PF614 + PlaceboPhase 2
44
PF614 + OxycodonePhase 1
25
PF614 + Naltrexone Hydrochloride + OxyContinPhase 1
25
PF614 + Oxycodone extended-release + Naltrexone HydrochloridePhase 1
25